External cataplasm matrix administration device
The utility model discloses an external cataplasm matrix dosing device which is characterized in that the dosing device comprises a material pipe (1), a mixing pipe (2) and a coating nozzle (3), an A-phase pipe (11) and a B-phase pipe (12) are arranged in the material pipe (1) side by side, and an A...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
13.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The utility model discloses an external cataplasm matrix dosing device which is characterized in that the dosing device comprises a material pipe (1), a mixing pipe (2) and a coating nozzle (3), an A-phase pipe (11) and a B-phase pipe (12) are arranged in the material pipe (1) side by side, and an A outlet pipe (111) at the outlet end of the A-phase pipe (11) and a B outlet pipe (121) at the outlet end of the B-phase pipe (12) are respectively communicated with a pipe cavity of the mixing pipe (2) internally provided with a turbofan (21). A material outlet (23) of the mixing pipe (2) is communicated with the coating nozzle (3); and the A-phase pipe (11) and the B-phase pipe (12) respectively adopt corresponding plunger rods (10). According to the drug delivery device, a matrix can be directly coated on an affected part, gel paste can be effectively adhered to the skin and is solidified and continuously adhered within 2-4 hours, and the paste body is in a solidified state when taken down and is uncovered; and |
---|---|
Bibliography: | Application Number: CN202223528618U |